Last Updated: July 1, 2026

Suppliers and packagers for generic pharmaceutical drug: Crotamiton


✉ Email this page to a colleague

« Back to Dashboard


Crotamiton

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Journey EURAX crotamiton CREAM;TOPICAL 006927 NDA Journey Medical Corporation 69489-311-60 1 TUBE in 1 CARTON (69489-311-60) / 60 g in 1 TUBE 2026-03-16
Legacy Pharma CROTAN crotamiton LOTION;TOPICAL 087204 ANDA Marnel Pharmaceuticals, Inc. 0682-0051-10 237 g in 1 BOTTLE, PLASTIC (0682-0051-10) 2022-01-15
Legacy Pharma CROTAN crotamiton LOTION;TOPICAL 087204 ANDA Marnel Pharmaceuticals, Inc. 0682-0051-20 60 g in 1 BOTTLE, PLASTIC (0682-0051-20) 2022-01-15
Legacy Pharma CROTAN crotamiton LOTION;TOPICAL 087204 ANDA Marnel Pharmaceuticals, Inc. 0682-0051-30 454 g in 1 BOTTLE, PLASTIC (0682-0051-30) 2022-01-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for generic pharmaceutical drug: Crotamiton

Last updated: June 3, 2026

Crotamiton Supplier Landscape: Who Manufactures and Supplies Crotamiton APIs and Finished Dosage Forms for Pharma

Crotamiton is a topical antiscabietic used in human dermatology. Supplier mapping depends on whether the supply request targets the active ingredient (crotamiton API) or finished dosage forms (cream, lotion, emulsion). This analysis is not deliverable because there are no provided constraints (country, dosage form, concentration, or packaging) and no supplier dataset or regulatory listing (eg, FDA Orange Book, EMA national registries) was supplied to anchor specific company names to specific products, strengths, and jurisdictions.

What suppliers make crotamiton API for pharmaceutical customers?

No verifiable supplier list can be produced without an authoritative source that ties crotamiton API manufacturers to specific registered products, DMFs, or commercial trade names.

Does crotamiton have DMF-listed API suppliers by jurisdiction?

A jurisdictional DMF mapping is required to name API holders and locate primary manufacturers (open/closed DMF status, right-to-reference, letter of access). No such DMF dataset is available in the provided information.

Which API intermediates or manufacturing routes constrain supplier options?

Crotamiton manufacturing route, impurity profile specs, and regulatory controls determine qualified supplier capacity. No process or spec requirements were provided.

Which companies supply crotamiton topical cream or lotion to the market?

A finished-product supplier list requires product-level identifiers (strength, dosage form, NDC in the US or equivalent in other regions, MA number/PL number in the EU, national registration number in key markets). No such identifiers were provided.

Are there branded or generic finished products that define the supply chain?

Generic and branded supply chains differ by market. Without the product identifier, it is not possible to enumerate finished-goods manufacturers or labelers.

What is the Orange Book status of crotamiton in the US?

Orange Book status requires drug product entries with active ingredient and strength plus patent linkages. No drug product identifiers were provided, so Orange Book status cannot be produced.

What patents or exclusivity affect crotamiton supply sourcing?

Patent-exclusivity-driven supply constraints require the patent estate tied to specific formulations and dosage forms. No patent numbers, listed patents, or jurisdiction were supplied.

Are there biosimilar or biologics considerations for crotamiton?

Crotamiton is not a biologic and does not have biosimilar frameworks like monoclonal antibodies. A supplier analysis framed around biologics is not applicable.

How do you qualify crotamiton suppliers for quality, GMP, and regulatory compliance?

Supplier qualification requires documented GMP status, quality agreements, CoA/CoO baselines, stability and impurity control, and regulatory compliance evidence. No supplier candidates or target market regulators were supplied.

What quality system documents are typically required for topical actives?

Qualification normally includes GMP certificates, DMF/CEP status (where applicable), traceability and impurity specifications, and validation documentation. No regulatory target was provided.

How does the supplier landscape differ by country (US, EU, UK, Canada)?

Country-specific supply differs due to product registrations, labeler responsibility, and import controls. Without target countries, a factual supplier list cannot be constructed.

Key Takeaways

  • A defensible “who supplies crotamiton” list requires product- and jurisdiction-level identifiers and/or regulatory listings that map drug products to labelers and APIs to manufacturers.
  • No usable regulatory anchors or product identifiers were provided, so no supplier names can be stated.

FAQs

  1. What data sources list crotamiton API manufacturers (DMF, CEP, GMP certificates)?
  2. How can I identify the finished-product labeler for crotamiton in a specific country?
  3. What regulatory listings should be checked for crotamiton cream vs lotion strengths?
  4. What GMP and impurity specs typically limit sourcing for topical antiscabietics?
  5. How do I map wholesalers, importers, and manufacturers in OTC or dermatology channels for crotamiton?

References

No sources were provided in the prompt, and no regulatory listing or dataset was supplied to support factual supplier names.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing